Gastrointestinal Cancer News

The continuous, long-term use of low-dose aspirin and NSAIDs appeared to reduce the risk for colorectal cancer, according to results of a population-based, case-control study conducted in Denmark.

CHICAGO — Encouraging data on using immunotherapy and a new chemotherapy combination to treat gastrointestinal cancers were revealed at the ASCO annual meeting.

Stress hormones are released when the body responds to physical, mental or emotional pressures.

The FDA granted orphan drug designation to varlitinib — an oral, novel pan-HER inhibitor — for the treatment of patients with cholangiocarcinoma, according to a press release from the drug’s manufacturer.

The BRAF V600 oncogene appeared targetable in certain nonmelanoma cancers, according to the results of a phase 2 study.

An increased risk for colorectal cancer was found to be associated with obesity in patients with Lynch syndrome, but regularly taking aspirin reversed the risk, according to study results.

Scientists may have found a way to develop a new blood test for liver cancer using technology that is currently being used to analyze rocks and minerals, according to data presented at The Goldschmidt Conference in Prague.

A single nucleotide polymorphism of KRAS mRNA, rs61764370, may serve as a biomarker of response to neoadjuvant treatment and a predictor of favorable outcomes for patients with locally advanced rectal cancer, according to the results of a randomized phase 2 study.

Sirtex Medical Inc. announced its dose sales for SIR-Spheres Y-90 resin microspheres have increased by 21.2% in the U.S. for the second quarter of 2015 compared to the second quarter of 2014, according to a press release.

Researchers in Sweden found that women with intrahepatic cholestasis of pregnancy had an increased risk for developing late liver and biliary tree cancer, immune-mediated diseases and cardiovascular disease, according to published findings in the Journal of Hepatology.